Komori
Mental Health Technologies (9218) · TargetRestated

Exceeding Break-Even after the Investment Phase and Achieving Profitability Early

First written in FY2021. 9 of 15 entries say "Restated". Latest entry: 2026-08-14.

15entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY2023WorsenedFY2024-Q1 – FY2024-H1AchievedFY2025-H1 – FY20252022: 420222023: 320232024: 320242025: 120252026: 42026
Same theme, other companies
Targets for Reducing Operating and Ordinary LossesA theme 52 companies write about · 2 as a headwind · 52 as a tailwind

The whole theme swung hardest in 2018: 2 of 14 companies on the "Worse" side.

9 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 52 companies compared. The sentences above are computed from all 52.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-14RestatedFinancial results briefing materials

    「Both revenue and profit came in above the six-month plan.」

    The company maintained profitability and reported that revenue and profit for the interim period exceeded the six-month plan.
  2. FY2026-H1RestatedAnnual report

    「As a result, for the interim consolidated accounting period, net sales were ¥4,097,811 thousand, up 35.5% year on year; operating profit was ¥294,069 thousand, up 6.0%; ordinary profit was ¥270,142 thousand, up 6.3%; and interim net income attributable to owners of the parent was ¥138,891 thousand, down 10.9%.」

    Operating profit, ordinary profit and interim net income remained positive during the interim period.
  3. FY2025AchievedAnnual report

    「As no such one-time expenses were incurred during the current consolidated fiscal year, we achieved higher revenue and profits and returned to profitability as described above.」

    The company returned to profitability after the FY2024 loss caused by one-time expenses, supported by a return to its recurring-revenue model and the absence of such expenses. FY2025 operating profit was ¥598,776 thousand, ordinary profit ¥438,418 thousand and net income attributable to owners of the parent ¥254,901 thousand.
  4. 2026-03-06AchievedGeneral Meetings of Shareholders

    「The previous consolidated fiscal year ended in a loss because we recorded one-time expenses related to the acquisition of Taskforce, amortization of goodwill and share-based compensation expenses for the 11th series of stock acquisition rights granted in May 2022. During the consolidated fiscal year under review, however, we returned to our underlying recurring-revenue structure and returned to profitability.」

    The disclosure states that the company moved from a loss in the previous consolidated fiscal year to profitability in the fiscal year ended December 2025.
  5. FY2025-H1AdvancedAnnual report

    「The previous interim consolidated accounting period was loss-making because we recorded expenses related to the acquisition of Taskforce, goodwill amortization and share-based compensation for the 11th series of stock acquisition rights granted in May 2022. During the current interim consolidated accounting period, however, we returned to our underlying recurring-revenue model and became profitable. As a result, net sales were ¥3,023,829 thousand, up 32.9% year on year; operating profit was ¥278,206 thousand, compared with an operating loss of ¥101,691 thousand; ordinary profit was ¥255,050 thousand, compared with an ordinary loss of ¥151,856 thousand; and interim net income attributable to owners of the parent was ¥156,121 thousand, compared with an interim net loss of ¥202,999 thousand.」

    The company returned to profitability from the FY2024 first-half loss as it returned to its recurring-revenue model, reporting operating profit of ¥278,206 thousand, ordinary profit of ¥255,050 thousand and interim net income attributable to owners of the parent of ¥156,121 thousand.
  6. FY2024-H1WorsenedAnnual report

    「As a result, for the interim consolidated accounting period, net sales were ¥2,275,812 thousand, up 74.5% year on year; operating loss was ¥96,283 thousand, compared with operating profit of ¥216,713 thousand; ordinary loss was ¥146,520 thousand, compared with ordinary profit of ¥212,949 thousand; and interim net loss attributable to owners of the parent was ¥202,151 thousand, compared with interim net income of ¥158,118 thousand.」

    Revenue rose substantially, but the company swung from operating profit, ordinary profit and interim net income to losses due to Taskforce acquisition-related one-time expenses, goodwill amortization and share-based compensation.
  7. FY2024-Q1WorsenedAnnual report

    「As a result, for the first quarter cumulative period, net sales were ¥869,359 thousand, up 25.7% year on year; operating loss was ¥235,807 thousand, compared with operating profit of ¥137,016 thousand; ordinary loss was ¥273,087 thousand, compared with ordinary profit of ¥134,109 thousand; and net loss attributable to owners of the parent was ¥285,942 thousand, compared with net income of ¥97,553 thousand.」

    Although revenue increased, acquisition-related one-time expenses for Taskforce, amortization of goodwill and share-based compensation resulted in operating, ordinary and quarterly net losses, temporarily weakening profitability.
  8. FY2023RestatedAnnual report

    「As a result, for the consolidated fiscal year, net sales were ¥2,608,600 thousand, up 14.0% year on year; operating profit was ¥501,093 thousand, up 35.5%; ordinary profit was ¥495,854 thousand, up 43.4%; and net income attributable to owners of the parent was ¥441,371 thousand, up 66.5%.」

    The company maintained profitability after exceeding break-even, with operating profit, ordinary profit and net income all increasing year on year in fiscal 2023.
  9. FY2023-Q3RestatedAnnual report

    「As a result, for the nine-month cumulative period, net sales were ¥1,935,466 thousand, up 9.9% year on year; operating profit was ¥353,904 thousand, down 15.6%; ordinary profit was ¥349,352 thousand, down 12.1%; and profit attributable to owners of the parent was ¥265,266 thousand, down 11.8%.」

    Operating profit, ordinary profit and quarterly net income remained positive for the nine-month period.
  10. FY2023-Q2RestatedAnnual report

    「As a result, for the second quarter cumulative period, net sales were ¥1,304,409 thousand, up 10.6% year on year; operating profit was ¥216,713 thousand, down 31.2%; ordinary profit was ¥212,949 thousand, down 27.6%; and profit attributable to owners of the parent was ¥158,118 thousand, down 29.9%.」

    Operating profit, ordinary profit and quarterly net income remained positive, although profit declined year on year.
  11. FY2023-Q1RestatedAnnual report

    「As a result, for the first quarter cumulative period, net sales were ¥691,565 thousand, up 20.5% year on year; operating profit was ¥137,016 thousand, down 18.1%; ordinary profit was ¥134,109 thousand, down 10.2%; and profit attributable to owners of the parent was ¥97,553 thousand, down 20.2%.」

    Operating profit, ordinary profit and quarterly net income remained positive, although each declined year on year.
  12. FY2022-Q3RestatedAnnual report

    「As a result, for the nine-month period, net sales were ¥1,761,133 thousand, operating profit was ¥419,136 thousand, ordinary profit was ¥397,290 thousand and profit attributable to owners of the parent was ¥300,847 thousand.」

    Operating profit, ordinary profit and quarterly net income remained positive for the nine-month period.
  13. FY2022-Q2RestatedAnnual report

    「As a result, for the second quarter cumulative period, net sales were ¥1,179,742 thousand, operating profit was ¥315,180 thousand, ordinary profit was ¥294,022 thousand and profit attributable to owners of the parent was ¥225,667 thousand.」

    Operating profit, ordinary profit and quarterly net income remained positive for the six-month period.
  14. FY2022-Q1RestatedAnnual report

    「As a result, for the first quarter cumulative period, net sales were ¥573,903 thousand, operating profit was ¥167,299 thousand, ordinary profit was ¥149,378 thousand and profit attributable to owners of the parent was ¥122,312 thousand.」

    Operating profit, ordinary profit and quarterly net income remained positive in the first quarter from January to March 2022.
  15. FY2021First statedAnnual report

    「Accordingly, we believe that achieving profitability early through improved earnings power and strengthening our financial position are important issues. During the current consolidated fiscal year, we began to exceed break-even as earnings improved in the mental health solutions and medical career support businesses due to increases in contracted companies and physician job openings and applications. We reported operating profit of ¥138,281 thousand and were profitable at every profit level.」

    After reporting losses and negative operating cash flow in 2019 and 2020, the company reported operating profit of ¥138,281 thousand, ordinary profit of ¥136,051 thousand and net income attributable to owners of the parent of ¥161,833 thousand in fiscal 2021.
Moved together

"Increasing the Enterprise Customer Ratio" moved the same way as this thread, in the same document, in 2 of its 15 moves.

222222★123456
  1. ★This thread
  2. 1Increasing the Enterprise Customer Ratio2×
  3. 2Dilution of Existing Shareholders Through the Exercise of Stock Acquisition Rights2×
  4. 3Economic Uncertainty Resulting from the Situation in Ukraine, Sharp Yen Depreciation and Other Factors2×
  5. 4Expansion into Mental Clinic Operations Support and Personal Training Gyms2×
  6. 5Expanding the Task-Shifting Business through the Acquisition of Taskforce2×
  7. 6Business and Earnings Impact of the Spread of COVID-192×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mental Health Technologies yet. It last moved in the Financial results briefing materials of 2026-08-14: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Exceeding Break-Even after the Investment Phase and Achieving Profitability Early | Mental Health Technologies Co.,Ltd. (9218) | Komori